Human cytomegalovirus matrix protein PP150 is efficiently presented as one of target antigens for cytotoxic T lymphocyte recognition

Chinese Medical Journal

Volumn 110, Issue 5, 1997, Pages 397-400

  Li, Chengrong ^a   Yang, Xiqiang ^a   Tu, Wenwei ^a   Riddell, Stanley R ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; PHOSPHOPROTEIN; PP150 PROTEIN, CYTOMEGALOVIRUS; RECOMBINANT PROTEIN; VIRUS ANTIGEN;

ARTICLE; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; CYTOTOXICITY; HUMAN; IMMUNOLOGY; SKIN; T LYMPHOCYTE; VIROLOGY;

ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; PHOSPHOPROTEINS; RECOMBINANT PROTEINS; SKIN; T-LYMPHOCYTES; VIRAL MATRIX PROTEINS;

EID: 0031129897     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Sissons JGP, Borysiewicz LK, Rodgers B, et al. Cytomegatovirus: its cellular immunology and biology. Immunol Today 1986; 7: 57.
2. Meyers JD, Fluornoy N, Thomas ED. Risk factors for cytomegalovirus infection after human bone marrow transplantation. J Infect Dis 1986; 153: 478.
3. Macher AM, Riechert CM, Straus SC, et al. Death in AIDS patient: role of cytomegalovirus. N Engl J Med 1983; 509: 1454.
4. Reusser P, Riddell SR, Meyers JD, et al. Cytotoxic T lymphocyte response to cytomegalovirus following human allogeneic bone marrow transplantation: pattern of recovery and correlation with cyto-megalovirus infection and disease. Blood 1991; 78:1373.
5. Li CR, Greenberg PD, Mark JG, et al. Recovery of MHC-restrcted cytomegalovirus (CMV)-specific T cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclover prophylaxis. Blood 1994; 83: 1971.
6. Mackett M, Smith GI, Moss B. The construction and characterization of vaccinia virus recombinant expression foreign genes. In Glover D, ed. DNA Cloning. Vol. II, Oxford: IRL Press, 1985: 191-211.
7. Riddell SR, Rabin M, Geballe AP, et al. Human cytomegalovirus-specific cytotoxic lymphocytes recognize infected cells in the absence of viral gene expression. J Immunol 1991; 146: 2795.
8. Walthen M, Stinski M, Temporal pattern of human cytomegalovirus transcription: mapping the viral PNAs synthesized at immediate early, early, and late times after infection. J Virol 1982; 41: 462.
9. Mark JG, Riddell SR, Li CR, et al. Selective interference with class I MHC presentation of the major immediate early protein following infection with human cytomegalovirus. J Virol 1993; 67: 3461.
10. + virus-specific CTL. J Med Virol 1994; 43: 103.
11. Braciale TJ, Morrison LA, Sweetser ML, et al. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol Rev 1987; 98: 95.
12. Yewdell J, Bennick JR, Hosaka Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 1988; 239: 637.